(Q86832296)

English

Blood pressure and glycaemic effects of dapagliflozin versus placebo in patients with type 2 diabetes on combination antihypertensive therapy: a randomised, double-blind, placebo-controlled, phase 3 study

scientific article published on 27 November 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26620248%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Blood pressure and glycaemic effects of dapagliflozin versus placebo in patients with type 2 diabetes on combination antihypertensive therapy: a randomised, double-blind, placebo-controlled, phase 3 study (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26620248%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

based on heuristic

inferred from title

type 2 diabetes

1 reference

based on heuristic

inferred from title

corrigendum / erratum

Correction to Lancet Diabetes Endocrinol 2015; published online Nov 24. http://dx.doi.org/10.1016/S2213-8587(15)00417-9

0 references

author name string

Michael A Weber

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26620248%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Traci A Mansfield

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26620248%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Valerie A Cain

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26620248%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Nayyar Iqbal

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26620248%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Shamik Parikh

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26620248%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Agata Ptaszynska

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26620248%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

publication date

27 November 2015

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26620248%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

The Lancet: Diabetes & Endocrinology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26620248%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26620248%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26620248%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

211-220

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26620248%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Pleiotropic effects of type 2 diabetes management strategies on renal risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900417-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900417-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Discovery of dapagliflozin: a potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900417-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900417-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with glimepiride: a randomized, 24-week, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900417-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A study of dapagliflozin in patients with type 2 diabetes receiving high doses of insulin plus insulin sensitizers: applicability of a novel insulin-independent treatment

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900417-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Dapagliflozin lowers blood pressure in hypertensive and non-hypertensive patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900417-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900417-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900417-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Triple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide: a randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900417-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Ambulatory blood-pressure monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900417-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevated systolic blood pressure as a cardiovascular risk factor

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900417-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of sodium-glucose co-transporter 2 inhibitors on blood pressure: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900417-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Empagliflozin reduces blood pressure in patients with type 2 diabetes and hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900417-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Thiazide and loop diuretics

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900417-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypothesis: Beta-adrenergic receptor blockers and weight gain: A systematic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900417-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900417-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S2213-8587(15)00417-9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26620248%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26620248%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q86832296&oldid=1529040357"